The effect of the iron chelator, desferrioxamine, on transferrin binding, growth rates and the cell cycle was investigated in the human leukaemic cell line, K562. At all concentrations of the chelator (2-50,uM) binding of 1251-transferrin was increased by 24 h and reached a maximum at 72-96 h. Maximum binding (6-8-fold increased) occurred in cells treated with 20 /tM-desferrioxamine, in contrast with control cells which, at 96 h, showed a 5000 decrease over initial binding. Scatchard analysis at 4°C showed that this increased binding was due to an increase in the number of receptors, as the Kd was similar in induced (1.8 nM) and control (1.5 nM) cells. After 96 h cells, cultured with 20 and 50 /M-desferrioxamine accumulated 59Fe from bovine transferrin at over twice the rate found with control cells, reflecting the increase in transferrin receptors. Although iron uptake was unimpaired by the chelator there was a dose-dependent inhibition of cell growth, with control cells completing three divisions in 96 h and those in 10 ,M-desferrioxamine only two divisions. At the highest concentration (50 /LM), cell division was abrogated although cell viability was maintained (85%). In contrast, DNA synthesis was not markedly affected, except at 50,uM-desferrioxamine when incorporation of [3H]thymidine was 52% of that in control cells. Flow cytometry revealed that there was a progressive accumulation of the cells in the active phases of their cycle (S, G2 + M). Desferrioxamine may increase transferrin receptors in two ways: (1) by chelating a regulatory pool of iron within the cell, and (2) by arresting cells in S phase when receptors are maximally expressed.
INTRODUCTION
Transferrin is required by cells proliferating in culture (Hutchings & Sato, 1978) to transport iron into the cell (Rudland et al., 1977; Cherington et al., 1979; Perez-Infante & Mather, 1982) . Cells acquire iron from transferrin by the process of receptor-mediated endocytosis (Karin & Mintz, 1981) in which, following binding to a specific cell-surface receptor, iron-rich transferrin enters a population of acidic vesicles (van Renswoude et al., 1982; Dickson et al., 1983) where iron is released from the protein. The iron-depleted but undegraded protein is then recycled to the plasma membrane and released from the cell (Bomford et al., 1985) .
Several factors appear to be involved in the regulation of these receptors. Receptor numbers are related to cell proliferation so that their density decreases as a population of cells moves from rapid cell division to confluence (Larrick & Cresswell, 1979; Hamilton et al., 1979; Sutherland et al., 1981; Trowbridge & Omary, 1981) . This is also reflected in their modulation during the cell cycle, with high receptor density on cells in S-phase and low density on G1 cells (Chitambar et al., 1983; Musgrove et al., 1984) . The iron available to the cells in the culture medium is also important because the number of receptors falls on cells grown in iron-supplemented media (Ward et al., 1982a,b; Louache et al., 1984) . Conversely, when the availability ofiron to cells is limited by the presence of the iron chelating agents desferrioxamine (Mattia et al., 1984; Bridges & Cudowicz, 1984) or picolinic acid (Louache et al., 1984) there is a 3-4-fold increase in transferrin receptors.
Clearly there is a complex relationship between expression oftransferrin receptors and cell growth on one hand and availability of iron on the other. To investigate further the regulatory role of iron on cell growth as well as expression of the transferrin receptor we have cultured the human leukaemic cell line, K562, in the presence of the iron chelating agent desferrioxamine for periods up to 96 h. Experiments were performed to determine whether transferrin iron in the culture medium was taken up by the cells under these conditions. Transferrin receptors were measured by the binding of radiolabelled human transferrin to intact cells and analysis of the cell cycle performed by flow cytometry.
were initiated by diluting a culture of cells, that had been maintained in exponential-phase growth for at least three passages, to between 0.7 x 105 and 0.9 x 105 cells/ml. After 24 h, when cell densities ranged from 0.9 x 105 to 1.5 x 105 cells/ml, desferrioxamine (Ciba Laboratories, Horsham, Sussex, U.K.) was added from a 1 mm stock solution made up in sterile water to give final concentrations of 2-50 /LM. The same volume of sterile water was added to control cultures. In some experiments ferrous ammonium sulphate was added to the chelator to half or fully saturate it with iron before addition to the cells. Cultures were sampled at intervals up to 96 h for the following studies.
Preparation and labelling of transferrin
Transferrin was purified from pooled human plasma by repeated DEAE-Sepharose chromatography and the iron-rich protein (470/410 nm absorbance ratio > 1.3) labelled with 1251 (Amersham International) by using solid-phase lactoperoxidase treatment (Bomford et al., 1983; Young et al., 1984) . Foetal calf serum was labelled with 59Fe (Amersham International) as previously described (Cavill, 1971) and was passed over an anion-exchange resin to remove non-specifically bound 59Fe (Cavill, 1971) .
Transferrin binding and iron uptake by cells
Transferrin binding was measured as described previously (Bomford et al., 1983; Young et al., 1984) by incubating 0.5 x 106-1 .5 x 106 washed cells with up to 310 nM-'251-transferrin in MEM containing 1% bovine serum albumin and 25 mM-Hepes, pH 7.5, under CO2/air (1:19). Incubations at 4°C were stopped after 75 min or at 37°C after 30 min by the addition of ice-cold PBS. Cells were recovered by centrifugation (800 g) and washed three times in PBS at 4 'C. Non-specific binding was estimated by adding a 100-fold excess of unlabelled transferrin to a parallel incubation. Cells were counted for radioactivity in a y counter. Iron uptake was measured by incubating cells (15 x 106-20 x 106) at 37 'C in MEM containing 25 mM-Hepes, pH 7.5, and 10% (v/v) foetal calf serum in which the transferrin was labelled with 59Fe. Non-specific binding was estimated in the presence of 62.5 ,tM human transferrin and cell harvesting and counting was performed as above.
Uptake of 13Hlthymidine DNA synthesis was measured by incorporation of [3H]thymidine (21 Ci/nmol; Amersham International) into acid-precipitable materials as described previously (Testa et al., 1982 the end of this period. Increased binding as compared with control cells was found at all concentrations of the chelator tested, with the maximum (6-8-fold increase) found with 20 /M-desferrioxamine (Table 1) . A comparison ofthe binding ofligand at 4 "C (surface binding only) with that at 37°C (full complement of receptors; Klausner et al., 1983) indicated that the drug had little effect on the distribution of receptors between internal and cell-surface locations. In control cells and at all concentrations of the chelator, surface bound transferrin was 42 + 3 % (mean + S.D.) of total binding (Table 1 ).
The kinetics of the increase in transferrin binding was investigated by culturing cells in the presence or absence of 20 ,iM-desferrioxamine and measuring the specific binding of '251-transferrin every 24 h. As shown in Fig.  1 there was a small increase by 24 h with maximum binding occurring between 72 and 96 h. Binding of transferrin to the control cells gradually diminished with time, falling by 96 h to 50 % of the amount bound at the start of the incubation. This reduction in transferrin binding as cells grow to 'plateau-phase' has been previously noted for K562 cells (Frazier et al., 1982) and other types of cultured cells (Larrick & Creswell, 1979) . Thus, although in the experiment shown in Fig. 1 there was a 6-fold increase in binding compared with control cells, at 96 h the increase over initial binding was approx. 3-fold.
The affinity of binding of 1251-transferrin to the induced receptors was calculated by Scatchard (1949) analysis of an equilibrium binding experiment performed at 4 'C. The induced cells (Kd 1.8 nM) bound transferrin with similar affinity as control cells (Kd 1.5 nM). In this experiment cells induced with 20 ,M-desferrioxamine for 96 h were compared with control cells maintained in exponential-phase growth. From the value of the intercept with the abcissa (Fig. 2 ) the induced cells had 8 x 105 surface receptors as compared with 2.5 x 105 on control cells, a 3-fold increase. The possibility that desferrioxamine or ferrioxamine, the iron-saturated form of the chelator, influenced the binding of '251-transferrin to its receptor was also examined. Concentrations of both forms of the chelator up to 100 /SM added to an equilibrium binding experiment failed to affect the binding of transferrin to control cells (results not shown).
Ferrioxamine, in concentrations ranging from 2,lM to 100 /SM, had little inductive effect on transferrin receptors (Table 2 ) and when the chelator was only 50% saturated with iron, so that the effective concentration of desferrioxamine was reduced to half the original concentration, the remaining agent had the inductive effect on transferrin receptors expected from the results in Table 1 . Thus, in the absence of ferrioxamine, 20#,M-desferrioxamine produced a 560% increase in transferrin binding at 96 h while, in the presence of the 25,uM-desferrioxamine remaining in the half-saturated 50,/lM culture, the increase was 700% (Table 2) . After 96 h the cells were washed three times at 37°C in MEM containing 25 mM-Hepes and resuspended in this medium containing 10% (v/v) 59Fe-labelled foetal calf serum. The incubations were performed at 37°C and contained desferrioxamine at the original concentration.
At intervals cells (1 x 1 06-2 x 106) were removed and washed three times in PBS at 4°C and counted for radioactivity in a y counter. Shown is the uptake of 59Fe by control cells and desferrioxamine-treated cells. Radioactivity was corrected for non-specific binding which was estimated in the presence of 62.5 /tM-human transferrin. A, control; *, 20 #M-desferrioxamine; *, 50 /tM-desferrioxamine.
Effect of desferrioxamine on uptake of 59Fe
We investigated whether prolonged culture with the chelator interfered with the cellular uptake of iron by incubating cells that had been cultured with desferrioxamine for 96 h with foetal calf serum in which the transferrin was labelled with 59Fe. As shown in Fig. 3 The experiment in Fig. 4 in which cells cultured with increasing concentrations of the chelator were counted at intervals up to 96 h shows that the inhibition of cell growth was dose-dependent. At the end of the experiment the control cells had completed three divisions, increasing to 800o% of initial numbers, while in 10 /tM-desferrioxamine two divisions were completed, resulting in a 400%o increase; 50 /M-desferrioxamine abolished cell proliferation. Cell viability was maintained at 980 up to 20 /tM-desferrioxamine, but at the maximum concentration the cultures contained 10-1500 non-viable cells at 96 h. In contrast, the chelator produced little reduction (Table 3) except at the highest concentrations (50 /,M) which reduced the incorporation by nearly 50% compared with control cells. Lederman et al. (1984) have previously shown that at these concentrations the chelator does not inhibit the cellular transport of thymidine.
The iron-saturated form of the chelator had no effect on growth, since control cells and cells cultured in 100 /sM-ferrioxamine grew at the same rate (Fig. 5) . Fig.  5 also shows that cells cultured with 20 /uM-desferrioxamine, and with 50 /uM-desferrioxamine which had been half-saturated with iron to reduce the effective concentration of the chelator to 25 /SM, grew at similar rates and were 98% viable at 96 h. In agreement with the experiment in Fig. 4 , cells cultured in 50 JM-desferrioxamine did not grow and were 85% viable at 96 h.
Cell cycle analysis
The cells from the experiment shown in Fig. 4 were harvested at 96 h and the DNA content was analysed by flow cytometry (Fig. 6 ). In the control cultures approx. 53 O of cells were in G1 phase, 30% in S phase and 17% in G2 + M phases. As the concentration ofdesferrioxamine was increased there was a progressive accumulation of cells in S phase and a corresponding fall in the proportion of cells in G1. This effect was most marked at 50 /SM-desferrioxamine (Fig. 6, panel c) when 28% of the cells were in G1 and 39% and 32O% in S and G2+M respectively.
DISCUSSION
Our results show that desferrioxamine can inhibit the growth of K562 cells while increasing the binding of transferrin. This does not represent an increased affinity of the interaction between the ligand for its receptor but an increase in the number of transferrin receptors, a membrane protein which is usually maximally expressed on proliferating cells (Trowbridge & Omary, 1981; Sutherland et al., 1981) . A similar increase in transferrin receptors has been previously reported for K562 cells induced with either desferrioxamine (Mattia et al., 1984; Bridges & Cudkowicz, 1984) or picolinic acid (Louache et al., 1984) . We found that ferrioxamine, which crosses cell membranes only slowly (Bottomley et al., 1985) was without effect and since desferrioxamine does cross the Vol. 236 cell membrane and accumulates within the cell it has been suggested (Bottomley et al., 1985) that it acts by chelating a pool of intracellular iron involved in the regulation of transferrin receptor biosynthesis. Our results showing that iron uptake from transferrin was unimpaired in cells exposed to the chelator for 96 h are in agreement with a previous report in which iron uptake was studied after 24 h (Bridges & Cudkowicz, 1984) and provide support for the interpretation that intracellular iron is made unavailable by conversion to ferrioxamine rather than by prevention of uptake. In contrast picolinic acid, which appears to reduce membrane transport of iron at the concentration required to induce transferrin receptors (Louache et al., 1984) , may reduce the regulatory pool. A contributing mechanism by which iron could be made unavailable is its removal from transferrin by the chelator in the extracellular environment. This transfer occurs relatively slowly in simple buffers (Pollack et al., 1976) and further work will be required to determine whether this could be quantitatively important in the enriched media used for cell culture.
At the low concentrations of desferrioxamine (10 and 20 /M) used here we found that the chelator apparently selectively inhibited cell division while producing little inhibition of DNA synthesis ( It is apparent that high concentrations of desferrioxamine are required to inhibit DNA synthesis in established cell lines since we found there was little inhibition (10-20% ) at low concentrations, while 50 /kM-desferrioxamine reduced synthesis by only 50 0 (Table 3) . Complete inhibition has been achieved in previous studies using millimolar concentrations (Robbins & Pederson, 1970; Hoffbrand et al., 1976; Ganeshaguru et al., 1980) . Under these conditions there is probably inhibition of ribonucleotide reductase which is essential for DNA synthesis (Thelander & Reichard, 1979) . This enzyme, which provides the cell with a balanced supply of the four deoxyribonucleotides, contains non-haem bound iron and a tyrosyl free radical on which enzyme activity depends (Graslund et al., 1982) . Lederman et al. (1984) have reported that mitogenstimulated human lymphocytes accumulate in S-phase when exposed to micromolar concentrations of desferrioxamine, and we likewise find that the cells of an established human leukaemic line are prevented from traversing S-phase during 96 h culture. Other conditions that have been reported to induce S-phase arrest include the use of a monoclonal anti-(transferrin receptor) antibody to block transferrin binding to a human T-leukaemia cell line (Trowbridge & Lopez, 1982) and mitogen-stimulated human lymphocytes (Mendelsohn et al., 1982) . Cherington et al. (1979) found that hamster fibroblasts did not enter G2 if transferrin and iron salts were omitted from the culture medium and the inclusion of transferrin saturated with gallium in the culture medium of human leukaemia cells produced a concentration-dependent accumulation of cells in S-phase (Chitambar et al., 1983) . The additional finding, in the latter study, of increased transferrin receptors on cells arrested in S-phase means that the effects of transferringallium are very similar to those of desferrioxamine described in the present report.
In the short term, iron deprivation may thus increase transferrin receptors by chelating a regulatory pool of iron and also by arresting cells in the active phases of the cell cycle when receptor expression is maximal (Musgrove et al., 1984; Chitambar et al., 1983 ). An explanation of why cells are particularly sensitive to iron depletion in S-phase could be provided by the recent observation that ribonucleotide reductase, which is iron-dependent, is also cell-cycle dependent and is synthesized in large amounts in S-phase (Eriksson et al., 1984) .
In conclusion, the results of the present study, showing that it is possible to inhibit cell proliferation selectively while leaving DNA synthesis intact, indicate that iron is needed at several points in the cycle ofcell maturation and division, but that the requirement for iron varies for the different components involved.
